0000919574-15-008551.txt : 20151207
0000919574-15-008551.hdr.sgml : 20151207
20151207105456
ACCESSION NUMBER: 0000919574-15-008551
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151203
FILED AS OF DATE: 20151207
DATE AS OF CHANGE: 20151207
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celator Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001327467
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 303B COLLEGE ROAD EAST
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: (609) 243-0123
MAIL ADDRESS:
STREET 1: 303B COLLEGE ROAD EAST
CITY: PRINCETON
STATE: NJ
ZIP: 08540
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morenstein Scott D
CENTRAL INDEX KEY: 0001576113
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36179
FILM NUMBER: 151271691
MAIL ADDRESS:
STREET 1: C/O CAXTON ALTERNATIVE MANAGEMENT LP
STREET 2: 1330 SIXTH AVENUE, 20TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
4
1
p6926191.xml
OWNERSHIP DOCUMENT
X0306
4
2015-12-03
0
0001327467
Celator Pharmaceuticals Inc
CPXX
0001576113
Morenstein Scott D
C/O CAXTON ALTERNATIVE MANAGEMENT LP
1330 SIXTH AVENUE, 20TH FLOOR
NEW YORK
NY
10019
1
0
0
0
Common Stock
2015-12-03
4
P
0
5000
1.865
A
6277
D
This constitutes the weighted average purchase price. The prices range from $1.85 to $1.8693. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
These securities are owned by Scott D. Morenstein, who is the Reporting Person. The 1,123,612 shares of common stock previously reported on the Reporting Person's Form 4 are no longer being included because the Reporting Person does not have beneficial ownership of these securities.
/s/ Scott D. Morenstein
2015-12-07